Dose Escalating and Randomized, Placebo-Controlled, Double-Blind Study to Assess Safaty, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) in Healthy African Adults in Mali
Phase of Trial: Phase I
Latest Information Update: 01 Aug 2017
At a glance
- Drugs Malaria vaccine live attenuated-Sanaria (Primary)
- Indications Falciparum malaria
- Focus Adverse reactions; Therapeutic Use
- 27 Jul 2017 Planned End Date changed from 31 Jul 2017 to 28 Feb 2018.
- 27 Jul 2017 Planned primary completion date changed from 31 Jul 2017 to 28 Feb 2018.
- 27 Jul 2017 Status changed from active, no longer recruiting to recruiting.